According to Brean, Gilead Sciences GILD, EPS estimates have changed.
Brean reported a change in EPS estimates from $3.91 to $3.65 for FY11 and from $4.40 to $4.22 for FY12. Rating is set to Buy with a PT of $52.
Gilead closed yesterday at $35.34.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in